Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England




Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,582.40Bid: 1,582.80Ask: 1,583.00Change: 10.80 (+0.69%)Riser - Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,577.60High: 1,582.80Low: 1,570.60Yesterday’s Close: 1,571.60

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1582.40
Share Price SpacerBid
1582.80
Share Price SpacerAsk
1583.00
Share Price SpacerChange
0.69%10.80
Share Price SpacerVolume
959,740
Share Price SpacerOpen
1,577.60
Share Price SpacerHigh
1,582.80
Share Price SpacerLow
1,570.60
Share Price SpacerClose
1,571.60
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,946.00m £78,265.50m 1,500

52 Week High 1,648.80 52 Week High Date 3-DEC-2018
52 Week Low 1,408.80 52 Week Low Date 6-DEC-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2,476 433,397 468,088 21.471 73.70 80.00 5.06


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Lloyds, BP, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Aviva

Users who hold GSK also hold: Vodafone, BP, National Grid, Lloyds, Royal Dutch Shell B, Aviva, HSBC, Tesco, BT, Centrica


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

24-May-19
10:00:16
1,582.80
492
Sell* 
1,582.80
1,583.00
7,787
Trade Type:
Automatic execution

24-May-19
10:00:16
1,582.80
83
Sell* 
1,582.80
1,583.00
1,314
Trade Type:
Automatic execution

24-May-19
10:00:15
1,582.80
66
Sell* 
1,582.60
1,583.20
1,045
Trade Type:
Automatic execution




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-May-19Buy
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1511.68GBX9366730
10-May-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
09366739
01-May-19Buy
Trade Notifier Information for GlaxoSmithKline
Philip R Hampton held the position of Non-Executive Chairman at GlaxoSmithKline at the time of this trade.
 Philip R Hampton
1568GBX2,7908768116
View more Glaxosmithkline directors dealings >>


AllAtSea
Posts: 881
Opinion:No Opinion
Price:1,549.00
RE: Damned aussies ...
Mon 14:59
About £3m if ACCC vs Reckitt Benckiser is a guide. That'd buy you nearly two houses in Kensington and Chelsea.
Dinoken
Posts: 759
Opinion:No Opinion
Price:1,555.00
Damned aussies ...
Sun 11:45
From London South East no less - but I could not find it anywhere on this site. Wonder how much this is going to cost ?

GSK and Novartis have admitted breaching Australian consumer law around Voltaren Osteo Gel and Voltaren Emulgel pain relief products by making "false or misleading representations in the marketing" of the two products.

From January 2012 to March 2017, the companies marketed Osteo Gel as a more effective treatment for pain and inflammation caused by osteoarthritis than Emulgel. In fact, the two medications are "essentially the same".

A later hearing will take place to "determine penalties sought by the ACCC".
Stocktaker01
Posts: 1,344
Opinion:No Opinion
Price:1,547.20
Sale of cork facility
16 May '19
To thermofisher propping this up today.
DOGSINBRAZIL
Posts: 257
Opinion:Strong Buy
Price:1,539.00
RE: Yippie
16 May '19
Yeah investors are piling in a few trail results that are due this summer brokers are starting to get bullish on GSK for frist time in years P.E of 13 dividend soild lot s going on in the Labs things are looking good about time
riolto10
Posts: 1,936
Opinion:No Opinion
Price:1,540.00
RE: Yippie
16 May '19
Equivalent to a 25p rise today!
View more share chat for Glaxosmithkline (GSK) >>




Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.